new work, by Alfred Bartolucci of the University of Alabama at Birmingham and colleagues, was supported by aspirin-maker Bayer AG. The research team pooled the results of the nine trials that have tested the drug in the prevention of heart disease so...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Aspirin cuts heart attacks, not deaths or strokes
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account